Skip to main content

AstraZeneca profit misses forecasts and warns outlook hinges on COVID-19

The FTSE 100-listed drug maker reported that core operating profit slid 29% to $1.55 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.